Perinatal choline supplementation prevents learning and memory deficits and reduces brain amyloid Aβ42 deposition in AppNL-G-F Alzheimer’s disease model mice is a research paper published in PLoS ONE (2024). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R21 AG056901
NIH
Grant: RF1 AG057768
NIH
Grant: R01 AG045031
NIH
Grant: RF1 AG078299
National Institutes of Health
Grant: 5R01AG045031-04
BMP9 as a juvenile protective factor in cognitive aging
National Institutes of Health
Grant: 7RF1AG078299-02
MicroRNAs as Diagnostic and Prognostic Biomarker of Alzheimer's Disease
National Institutes of Health
Grant: 1R21AG056901-01A1
Therapeutic Effects of Dietary Choline Mediated by IGF2 in AD Mouse Model
National Institutes of Health
Grant: 1RF1AG057768-01A1
Age-Associated Lipidomic Changes in Alzheimer's Disease
NIH Office of Dietary Supplements
FWCI
4.20
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals